Jin-Mo Ku

Title: Jin-Mo Ku: Innovator in Obesity Treatment

Introduction

Jin-Mo Ku is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of obesity treatment through his innovative research and patented inventions. With a total of 3 patents, his work focuses on novel compounds that promote the differentiation of adipocytes.

Latest Patents

One of his latest patents is titled "Triazole derivative and use thereof." This invention relates to a novel triazole derivative or a salt thereof, which has the potential to induce or promote the browning of white adipocytes. The triazole derivative can differentiate stem cells, embryonic cells, or preadipocytes into brown or beige adipocytes. The composition derived from this invention is expected to treat, prevent, or alleviate various conditions such as obesity, diabetes, dyslipidemia, and metabolic syndrome. Another significant patent is "Method for treating, managing, inhibiting, or preventing obesity." This patent describes a composition that includes butein or its derivatives as an active ingredient, which induces differentiation into beige adipocytes from white adipocytes. The active ingredient has been confirmed to increase expressions of UCP-1 and PRDM4, making it a promising candidate for obesity treatment.

Career Highlights

Jin-Mo Ku has worked at prestigious institutions such as Sungkyunkwan University and the Gyeonggido Business & Science Accelerator. His research has garnered attention for its potential applications in the medical field, particularly in addressing obesity and its related complications.

Collaborations

He has collaborated with notable colleagues, including Kye Won Park and Nojoon Song, who have contributed to his research endeavors.

Conclusion

Jin-Mo Ku's innovative work in the field of obesity treatment showcases his dedication to advancing medical science. His patents reflect a commitment to finding effective solutions for obesity and its associated health issues.